{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:43:36Z","timestamp":1793817816266,"version":"4.6.1"},"reference-count":26,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T00:00:00Z","timestamp":1216684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> UVA exposure of human skin mainly produces reactive oxygen species (ROS) leading to DNA, cell and tissue damage. It alters immune function, pigmentation and it is certainly responsible for a large part of photoaging changes. Moreover UVA is implicated in the etiology of several photodermatoses. As a consequence, to provide adequate protection, sunscreens or skin care products for daily use protective products need UVA absorbers combined with UVB ones.<\/jats:p><jats:p><jats:bold>Aim: <\/jats:bold> To assess the efficacy of sunscreens containing a broad\u2010spectrum UVA absorber the Mexoryl<jats:sup>\u00ae<\/jats:sup> SX or ecamsule and to compare formulations with and without it through a large number of clinical studies in human volunteers and patients.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> The following assessments were conducted:<\/jats:p><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>Prevention of excessive pigmentation induced by UV exposure in Caucasian and Asian skins using a method that measures pigmentation protection factors (PPF).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Efficacy against DNA damage by measurement of pyrimidine dimer formation and p53 protein accumulation.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Protection of immune system using delayed type hypersensitivity (DTH) reactions to recall antigens, isomerization of urocanic acid (UCA), alteration of Langerhans cells (LC) density, morphology and function.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Reduction of epidermal and dermal alterations induced by repeated UVA or UV solar simulated radiation (SSR) using histology or immunohistology.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Prevention of the polymorphous light eruption (PMLE) in patients prone to develop this disease.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Mexoryl<jats:sup>\u00ae<\/jats:sup> SX\u2010containing formulations showed a dose\u2010dependent level of protection against pigmentation. For a same sun protection factor (SPF) the higher the UVA protection was, the higher was the PPF. Pyrimidine dimer formation and p53 accumulation were significantly reduced by formulations with Mexoryl<jats:sup>\u00ae<\/jats:sup> SX. In the studies looking at the suppression of DTH reactions to recall antigens by the different UV spectra, the LC alterations and the <jats:italic>cis<\/jats:italic> UCA formation, Mexoryl<jats:sup>\u00ae<\/jats:sup> SX formulations always showed a higher protective potency than sunscreen without it even when the protection against erythema was similar (products with same SPF). Mexoryl<jats:sup>\u00ae<\/jats:sup> SX formulations also prevented or significantly decreased to minimal, ferritin, tenascin and lysozyme expression induced by repeated UVA or SSR exposure. It also reduced the enhancement of collagenase 2 mRNA expression induced by SSR exposure. Finally PMLE study demonstrated that UVA protection was essential for the prevention of this photodermatose.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> Mexoryl<jats:sup>\u00ae<\/jats:sup> SX formulated in sunscreens or daily use products have been shown to be an effective UV absorber, leading to an increased efficacy of these products against a large number of biological damage induced by UVA, SSR or sun exposure.<\/jats:p>","DOI":"10.1111\/j.1600-0781.2008.00365.x","type":"journal-article","created":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T00:04:18Z","timestamp":1216771458000},"page":"164-174","source":"Crossref","is-referenced-by-count":77,"title":["Sunscreens containing the broad\u2010spectrum UVA absorber, Mexoryl<sup>\u00ae<\/sup> SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results"],"prefix":"10.1111","volume":"24","author":[{"given":"Anny","family":"Fourtanier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Moyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Seit\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,22]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12531710"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12465094"},{"key":"e_1_2_9_4_2","first-page":"15","volume-title":"Photoaging","author":"Moyal D","year":"2004"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(68)90168-9"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01773.x"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12285613"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(02)00461-1"},{"key":"e_1_2_9_9_2","first-page":"4954","article-title":"The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations","volume":"101","author":"Agar NS","year":"2004","journal-title":"a role for UVA in human skin carcinogenesis"},{"key":"e_1_2_9_10_2","first-page":"346","article-title":"Solar urticaria","volume":"118","author":"Hasei K","year":"1982","journal-title":"determinations of action and inhibition spectra Arch"},{"key":"e_1_2_9_11_2","first-page":"748","article-title":"Polymorphous light eruption","volume":"14","author":"Ortel B","year":"1986","journal-title":"action spectrum and photoprotection"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2004.00111.x"},{"key":"e_1_2_9_13_2","unstructured":"MoyalD.Prevention of pigmentation in Asian skin exposed to ultraviolet daylight. Proceeding of the International Federation of the Societies of Cosmetic Chemists (IFSCC) meeting Osaka Japan. October 2006."},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.2005.tb01456.x"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00012.x"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1996.tb03125.x"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2000.160103.x"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01545.x"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.11.s.1.7.x"},{"key":"e_1_2_9_20_2","first-page":"291","article-title":"Alterations in human epidermal Langerhans cells by ultraviolet radiation","volume":"148","author":"Seit\u00e9 S","year":"2003","journal-title":"quantitative and morphological study"},{"key":"e_1_2_9_21_2","first-page":"1161","article-title":"Ultraviolet A1 exposure of human skin results in Langerhans cell depletion and reduction of epidermal antigen\u2010presenting cell function","volume":"144","author":"Dumay O","year":"2001","journal-title":"partial protection by a broad-spectrum sunscreen"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1994.tb05105.x"},{"key":"e_1_2_9_23_2","first-page":"69","article-title":"Mexoryl\u00ae SX","volume":"44","author":"Seit\u00e9 S","year":"1998","journal-title":"a broad-spectrum UVA filter protects human skin from the effects of repeated suberythemal doses of UVA"},{"key":"e_1_2_9_24_2","first-page":"980","article-title":"Elastin changes during chronological and photo\u2010ageing","volume":"20","author":"Seit\u00e9 S","year":"2006","journal-title":"the important role of lysozyme"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12339292"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2000.160401.x"},{"key":"e_1_2_9_27_2","first-page":"611","volume-title":"Sunscreens: development, evaluation and regulatory aspects","author":"Moyal D","year":"1997"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0781.2008.00365.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0781.2008.00365.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:10:11Z","timestamp":1697062211000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0781.2008.00365.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,22]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1600-0781.2008.00365.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0781.2008.00365.x","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,22]]}}}